alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
BALANCE SHEET AND CONSOLIDATED STATEMENT OF OPERATIONS OF THIS QUARTERLY REPORT
ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           2,002
<SECURITIES>                                         0
<RECEIVABLES>                                    5,661
<ALLOWANCES>                                       496
<INVENTORY>                                      2,924
<CURRENT-ASSETS>                                11,997
<PP&E>                                          10,140
<DEPRECIATION>                                   7,424
<TOTAL-ASSETS>                                  16,575
<CURRENT-LIABILITIES>                           11,477
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                      58,259
<TOTAL-LIABILITY-AND-EQUITY>                    16,575
<SALES>                                          6,591
<TOTAL-REVENUES>                                 7,479
<CGS>                                            4,595
<TOTAL-COSTS>                                    5,113
<OTHER-EXPENSES>                                 3,459
<LOSS-PROVISION>                                 1,700
<INTEREST-EXPENSE>                                  18
<INCOME-PRETAX>                                 (2,807)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (2,807)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (2,807)
<EPS-PRIMARY>                                    (0.45)
<EPS-DILUTED>                                    (0.45)
        

</TABLE>
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 155 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
S. RES. 155

Establishing May 2, 2015, as a Day of Recognition for Ebola Orphans to 
  express support for the children and families affected by the 2014 
Ebola outbreak in West Africa by promoting awareness of the children of 
    West Africa who have been orphaned by the 2014 Ebola epidemic, 
 celebrating those who have recognized and are working to fulfill the 
   needs of those children, and encouraging the people of the United 
        States to continue to support the people of West Africa.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 29, 2015

  Mr. Inhofe (for himself and Ms. Klobuchar) submitted the following 
    resolution; which was referred to the Committee on the Judiciary

_______________________________________________________________________

                               RESOLUTION

 
Establishing May 2, 2015, as a Day of Recognition for Ebola Orphans to 
  express support for the children and families affected by the 2014 
Ebola outbreak in West Africa by promoting awareness of the children of 
    West Africa who have been orphaned by the 2014 Ebola epidemic, 
 celebrating those who have recognized and are working to fulfill the 
   needs of those children, and encouraging the people of the United 
        States to continue to support the people of West Africa.

Whereas the 2014 Ebola outbreak in West Africa reached epidemic proportions;
Whereas the World Health Organization reports that there have been over 14,800 
        laboratory-confirmed cases of Ebola in Guinea, Liberia, and Sierra Leone 
        as of April 19, 2015;
Whereas the World Health Organization reports that there have been over 10,800 
        deaths from Ebola in Guinea, Liberia, and Sierra Leone as of April 19, 
        2015;
Whereas the United Nations Children's Fund (UNICEF) estimates that as of 
        February 2015, nearly 11,000 children in West Africa have lost 1 or both 
        parents due to the 2014 Ebola outbreak;
Whereas some families reject Ebola orphans out of fear of the disease;
Whereas the United States authorized $750,000,000 to support up to 3,000 United 
        States troops in Monrovia, Liberia, to respond to the Ebola crisis; and
Whereas United States citizens have given time and resources to assist the 
        people of West Africa, including Ebola orphans: Now, therefore, be it
    Resolved, That the Senate--
            (1) recognizes May 2, 2015, as a Day of Recognition for 
        Ebola Orphans, to promote awareness of the children of West 
        Africa orphaned by the 2014 Ebola outbreak;
            (2) supports the goals and work of those who are addressing 
        the developing Ebola orphan crisis in West Africa; and
            (3) encourages the people of the United States to consider 
        the needs of the children of West Africa who were orphaned by 
        the 2014 Ebola epidemic.
                                 <all>
```
Order entered June 29, 2018

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-18-00010-CV

JOHN P. HAGAN, Appellant

V.

JAMES E. PENNINGTON, Appellee

On Appeal from the County Court at Law No. 5

Collin County, Texas

Trial Court Cause No. 005-00175-2017

ORDER

Before the Court is appellee’s June 18, 2018 motion for extension of the maximum word 

length for his brief. We GRANT the motion. We ORDER the brief tendered to this Court by 

appellee on June 18 filed as of the date of this order.

/s/ ADA BROWN 

JUSTICE
EXHIBIT 99.2





SPEEDCOM Wireless Corporation





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of SPEEDCOM Wireless Corporation (SPEEDCOM) on Form 10-QSB for the
period ending September 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Mark Schaftlein, Chief Financial Officer of SPEEDCOM, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:





(1)  The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of SPEEDCOM.





/s/    MARK
SCHAFTLEINMark Schaftlein Chief
Financial Officer





November 5, 2002
**RB** IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 1 9 - 06 6 6 STATE OF MONTANA,

Plaintiff and Appellee, v. LOUIS W. MIKESELL,

Defendant and Appellant.

**GRANT OF EXTENSION** Upon consideration of Appellee’s motion for a 30 - day extension of time, and good cause appearing therefor, Appellee is gran ted an extension of time to and including March 1 , 202 1 , within which to prepare, serve, and file its response brief.

Electronically signed by: Bowen Greenwood Clerk of the Supreme Court January 26 2021

01/26/2021
Case Number: DA 19-0666
[Federal Register Volume 82, Number 172 (Thursday, September 7, 2017)]
[Notices]
[Page 42277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19063]


=======================================================================
-----------------------------------------------------------------------

CHEMICAL SAFETY AND HAZARD INVESTIGATION BOARD


Sunshine Act Meeting

TIME AND DATE: September 18, 2017, 1:00 p.m. EDT.

PLACE: U.S. Chemical Safety Board, 1750 Pennsylvania Ave. NW., Suite 
910, Washington, DC 20006.

STATUS: Open to the public.

MATTERS TO BE CONSIDERED: The Chemical Safety and Hazard Investigation 
Board (CSB) will convene a public meeting on September 18, 2017, 
starting at 1:00 p.m. EDT in Washington, DC, at the CSB offices located 
at 1750 Pennsylvania Avenue NW., Suite 910. The Board will provide a 
summary of work completed in FY 2017 and discuss the CSB report on the 
ExxonMobil Baton Rouge Refinery incident. An opportunity for public 
comment will be provided.

Additional Information

    The meeting is free and open to the public. If you require a 
translator or interpreter, please notify the individual listed below as 
the ``Contact Person for Further Information,'' at least three business 
days prior to the meeting.
    A conference call line will be provided for those who cannot attend 
in person. Please use the following dial-in number to join the 
conference: 1-888-862-6557, Confirmation 45538361.
    The CSB is an independent federal agency charged with investigating 
accidents and hazards that result, or may result, in the catastrophic 
release of extremely hazardous substances. The agency's Board Members 
are appointed by the President and confirmed by the Senate. CSB 
investigations look into all aspects of chemical accidents and hazards, 
including physical causes such as equipment failure as well as 
inadequacies in regulations, industry standards, and safety management 
systems.

Public Comment

    The time provided for public statements will depend upon the number 
of people who wish to speak. Speakers should assume that their 
presentations will be limited to three minutes or less, but commenters 
may submit written statements for the record.

Contact Person for Further Information

    Hillary Cohen, Communications Manager, at <a href="/cdn-cgi/l/email-protection#017174636d6862416272632f666e77"><span class="__cf_email__" data-cfemail="b6c6c3d4dadfd5f6d5c5d498d1d9c0">[email protected]</span></a> or (202) 
446-8094. Further information about this public meeting can be found on 
the CSB Web site at: www.csb.gov.

    Dated: September 5, 2017.
Kara A. Wenzel,
Acting General Counsel, Chemical Safety and Hazard Investigation Board.
[FR Doc. 2017-19063 Filed 9-5-17; 4:15 pm]
 BILLING CODE 6350-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002



The undersigned executive officer of Black Rock Petroleum
Company certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

• the annual report on Form 10-K/A of the Company
for the year ended April 30, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and



• the information contained in the Form 10-K/A fairly
presents, in all material respects, the financial condition and results of operations of the Company.



|                        |                                                                                                       
|----------------------- | ------------------------------------------------------------------------------------------------------
|Date:  October 22, 2019 | /s/ Zoltan Nagy
        Zoltan Nagy
        Chief Executive Officer, Chief Financial Officer, Director
Exhibit 99.1
 
 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 To the Board of Directors and Shareholders of
 TriplePoint Venture Growth BDC Corp.:
 
 
 We have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated statements of assets and liabilities of TriplePoint Venture Growth BDC Corp. and subsidiaries (the “Company”), including the consolidated schedules of investments, as of December 31, 2019 and 2018, and the related consolidated statements of operations, changes in net assets and cash flows for each of the three years ended December 31, 2019, and the consolidated financial highlights for the years ended December 31, 2019, 2018, 2017, 2016, and 2015, and the related notes, and have issued our report thereon dated March 4, 2020. Such consolidated financial statements and financial highlights and our report thereon are included in Part II, Item 8 of the Company’s annual report on Form 10-K for the year ended December 31, 2019.
 In our opinion, the financial information set forth under the heading “Senior Securities” as of December 31, 2019, 2018, 2017, 2016, 2015 and 2014, included in Part II, Item 7 of the Company’s annual report on Form 10-K for the year ended December 31, 2019, is fairly stated, in all material respects, in relation to the consolidated financial statements from which it has been derived.
 
 /s/ Deloitte & Touche LLP
 San Francisco, California
 March 4, 2020
Exhibit 10.3





EXHIBIT 10.3




	 	 	 
	

	 	ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM ADMINISTRATION

DIVISION OF BUSINESS AND FINANCE
SECTION A: CONTRACT






	 	 	 	 	 	 	 
	1. AMENDMENT 


    NUMBER:

	2.   	CONTRACT 


NO.:
	3.   	EFFECTIVE DATE OF 

AMENDMENT:
	4.   	PROGRAM
	13

	 	YH09-0001-07
	 	October 1, 2010
	 	DHCM — ACUTE






5. CONTRACTOR’S NAME AND ADDRESS:



VHS Phoenix Health Plan, LLC

7878 N. 16th St., Suite 105

Phoenix, AZ 85020




6. PURPOSE OF AMENDMENT: To amend Section B, Capitation Rates, effective October 1, 2010
through September 30, 2011.



7. THE CONTRACT REFERENCED ABOVE FOLLOWS




To amend Section B, Capitation Rates, effective October 1, 2010 through September 30, 2011.




NOTE: Please sign, date, and return executed file by E-Mail to: Mark Held at
Mark.Held@azahcccs.gov



	 	 	 
	 

	 	Sr. Procurement Specialist
	 

	 	AHCCCS Contracts and Purchasing
	 

	 	and Stewart McKenzie at
	 

	 	Stewart.McKenzie@azahcccs.gov






8. EXCEPT AS PROVIDED FOR HEREIN, ALL TERMS AND CONDITIONS OF THE ORIGINAL
CONTRACT NOT HERETOFORE CHANGED AND/OR AMENDED REMAIN UNCHANGED AND
IN FULL EFFECT.




IN WITNESS WHEREOF THE PARTIES HERETO SIGN THEIR NAMES IN AGREEMENT



	 	 	 	 	 
	9. SIGNATURE OF AUTHORIZED
REPRESENTATIVE:

	 	 	 	10. SIGNATURE OF AHCCCSA
CONTRACTING OFFICER:
	 
	 	 	 	 
	/s/ Nancy Novick

	 	 	 	/s/ Michael Veit
	 

	 	 	 	 
	TYPED NAME: NANCY NOVICK

	 	 	 	TYPED NAME: MICHAEL VEIT
	TITLE: CHIEF EXECUTIVE OFFICER

	 	 	 	TITLE: CONTRACTS & PURCHASING ADMINISTRATOR
	 
	 	 	 	 
	DATE: 1-17-11

	 	 	 	DATE: JANUARY 5, 2011







 


 









 







ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM

REVISED CAPITATION RATE SUMMARY — CYE 11 ACUTE RATES RISK ADJUSTED WITH 100% OF CYE 10 FACTORS

Phoenix Health Plan

10/1/10-9/30/11




	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	TANF	 	 	TANF	 	 	TANF	 	 	TANF	 	 	TANF	 	 	SSI	 	 	SSI	 	 	 	 
	Title XIX and KidsCare Rates 1:	 	<1, M/F	 	 	1-13, M/F	 	 	14-44, F	 	 	14-44, M	 	 	45+, M/F	 	 	w/ Med	 	 	w/o Med	 	 	Non-MED	 
	4
	 	Apache/Coconino/Mohave/Navajo	 	$	540.94	 	 	$	114.08	 	 	$	275.59	 	 	$	166.92	 	 	$	377.04	 	 	$	107.68	 	 	$	816.24	 	 	$	460.93	 
	6
	 	Yavapai	 	$	553.24	 	 	$	113.10	 	 	$	284.63	 	 	$	179.62	 	 	$	415.24	 	 	$	133.51	 	 	$	875.73	 	 	$	566.85	 
	8
	 	Gila/Pinal	 	$	480.12	 	 	$	109.26	 	 	$	265.40	 	 	$	176.95	 	 	$	380.79	 	 	$	134.34	 	 	$	889.56	 	 	$	466.00	 
	10
	 	Pima	 	$	542.07	 	 	$	89.71	 	 	$	210.86	 	 	$	122.17	 	 	$	325.24	 	 	$	102.09	 	 	$	814.38	 	 	$	390.01	 
	12
	 	Maricopa	 	$	501.68	 	 	$	113.20	 	 	$	244.34	 	 	$	158.81	 	 	$	415.73	 	 	$	146.66	 	 	$	730.40	 	 	$	489.53	 








	 	 	 
	1.	 	Rates have been adjusted for $35,000 Reinsurance Deductible
**Exhibit31.2**

**Certifications**

     I,Philip L. Jones, certify that:

          1.I have reviewed this Quarterly Report on Form 10-QSB of Profile Technologies, Inc.;

          2.Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

          3.Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the small business issuer asof, and for, the periods presented in this report;

          4.The small business issuer’s other certifying officer and I are responsiblefor establishing and maintaining disclosure controls and procedures (as definedin Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control overfinancial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the small business issuer and have:

               (a)Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to the small business issuer, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;

               (b)(Paragraph omitted pursuant to SEC Release No. 33-8238.);

               (c) Evaluatedthe effectiveness of the small business issuer’s disclosure controls andprocedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period coveredby this report based on such evaluation; and

               (d)Disclosed in this report any change in the small business issuer’s internalcontrol over financial reporting that occurred during the small businessissuer’s most recent fiscal quarter that has materially affected, or isreasonably likely to materially affect, the small business issuer’sinternal control over financial reporting; and

          5.The small business issuer’s other certifying officer and I have disclosed,based on our most recent evaluation of internal control over financialreporting, to the small business issuer’s auditors and the audit committeeof the small business issuer’s board of directors (or persons performingthe equivalent functions):

               (a)All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the small business issuer’s ability to record, process,summarize and report financial information; and

               (b)Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the small business issuer’s internal controlover financial reporting.

Date: May 9,2007
<PAGE>
                                                                    EXHIBIT 31.2

                                  CERTIFICATION

I, Peter F. McAree, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Caliper Life Sciences,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

      a) designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under our supervision,
      to ensure that material information relating to the registrant, including
      its consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this report is being
      prepared;

      b) evaluated the effectiveness of the registrant's disclosure controls and
      procedures and presented in this report our conclusions about the
      effectiveness of the disclosure controls and procedures, as of the end of
      the period covered by this report based on such evaluation; and

      c) disclosed in this report any change in the registrant's internal
      control over financial reporting that occurred during the registrant's
      most recent fiscal quarter (the registrant's fourth fiscal quarter in the
      case of an annual report) that has materially affected, or is reasonably
      likely to materially affect, the registrant's internal control over
      financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

      a) all significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant's ability to record,
      process, summarize, and report financial information; and

      b) any fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant's internal control
      over financial reporting.

Date: August 9, 2004

/S/ Peter F. McAree
-----------------------
Peter F. McAree
Vice President, Finance
(Principal Financial Officer)
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED OCTOBER 9, 2020

NO. 03-20-00259-CV

N. J., Appellant

v.

Texas Department of Family and Protective Services, Appellee

APPEAL FROM THE 146TH DISTRICT COURT OF BELL COUNTY

BEFORE CHIEF JUSTICE ROSE, JUSTICES BAKER AND KELLY

REVERSED AND REMANDED -- OPINION BY JUSTICE KELLY

This is an appeal from the judgment signed by the trial court on March 27, 2020. Having 

reviewed the record and the parties’ arguments, the Court holds that there was reversible error in 

the court’s judgment. Therefore, the Court reverses the portions of the trial court’s judgment 

terminating N.J.’s parental rights and appointing the Department as permanent managing 

conservator of L.B. and remands the case to the trial court for a new trial. The appellee shall pay 

all costs relating to this appeal, both in this Court and in the court below.
# **Exhibit 32.2**

# **CERTIFICATION OF PRINCIPALFINANCIAL OFFICER PURSUANT TO 18 U.S.C. ss. 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Inconnection with the Quarterly Report of SIRONA Dental Systems, Inc. (the “Company”)on Form 10-Q for the period ended June 30, 2006, as filed with the Securitiesand Exchange Commission on the date hereof (the “Report”), I, Simone Blank,Executive Vice President and Chief Financial Officer, certify, pursuant to 18U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Actof 2002, that: 

(1)             The Report fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;and

(2)             The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.
|        |   | /S/ Simone Blank                                     |
|--------|--------|------------------------------------------------------|
|   |   | Simone Blank                                         |
|   |   | Executive Vice President and Chief Financial Officer |
|   |   | SIRONA Dental Systems, Inc.                          |
|   |   | August 8, 2006                                       |

 

----